Document 7KrymODnrdOb9pp2m6nR62YB

Eo 10oo)i) told HCoalt1I PCi.8pC(ti1C, S/lpplCOltS 101 (So pp1. (): .,-18 (199.)') Review of the Carcinogenic Potential of Gasoline by Gerhard K. Raabe This review examines the animal, human, and mechanistic studies that precede the new studies reported in this volume. Wholly vaporized unleaded gasoline was found to produce a dose-dependent increase in renal carcinoma in male rats and an excess above background incidence of hepatocellular tumors in female mice in the high-dose group. Mechanistic studies suggest that gasoline is not mutagenic and that the probable mechanism for the male rat renal tumors involves a rat-specific protein, nX9u-globulin, whose binding with highly branched aliphatic compounds results in renal tubule cell death and, in turn, a proliferative sequence that increases renal tubule tumors. Human evidence generated predominantly from studies of refinery workers does not support a kidney or liver cancer risk in humans. The current epidemiologic database is inadequate to access leukemia risk from low-level benzene exposure from gasoline. Studies of gasolineexposed workers that incorporate quantitative exposure information are needed. Introduction The reports that follow this review represent scientific inquiry into the carcinogenic potential of gasoline and its mechanism of action begun after 1983. To better understand these new studies and the dii-ection of their line of inquiry, it is important to at least briefly review the scientific developments that preceded this work. Because of the generally low acute toxicity of gasoline, it was not until the mid-1970s that the petroleum industry, through the American Petroleum Institute, began to consider the design of a chronic study of gasoline (1). Concern over the benzene content of gasoline was only beginning to be discussed in scientific literature. However, by this time, it was clear that leaded gasoline was to be phased out and that a chronic study of unleaded gasoline was needed. Chronic Study of Gasoline The fuel finally selected for study was custom blended to reflect the average 1976 unleaded summer-grade sold in the United States. The benzene content of the fuel was increased to 2% to reflect the then-current maximum levels. Other characteristics of test fuel are presented in Thble 1. The experimental design of the two-year study was intended to closely mimic the NCI bioassay (Table 2). The decision was also made to study wholly vaporized gasoline for an overall cancer hazard assessment, although exposure of gasoline distribution workers and the public would be expected to be the more volatile fraction (2). Mobil Oil Corporation, Corporate Medical Depar-tment, P.O. Box 1038, Princeton, NJ 08543-1038. This manuscript was presented at the Inter national Symposium on the Health Effects of Gasoline held 5-8 November 1991 in Miami, FL. Table 1. Study gasoline composition (2). Property Test material RO/MO RVP Distillation, TF F values for IBP through 100% distillation. 92/84 9.5 IBP 10% 50c% 90% 100%Xs SOA, % Benzene, % Lead, g/gallon 93 116 216 340 428 66/8/26 2 <0.05 Abbreviations: SOA, saturates, olefins, aromatics; RO, roa(d octane; MO, motor octane; IBP, initial boiling point. Table 2. Experimental design two-year chronic study (2). Parameter Description Animals Concentration Exposure Interim kills 100 per sex per species per dose; Fischer-344 rat and B6C3F, mouse 0, 67, 292, 2056 ppm wholly vaporized unleaded gasoline 6 hr/day, 5 days/week, 103-113 weeks in 16-in chambers 10 pei sex, species, and gr'oup at 3, 6, 12, 18 months The principal results of the chronic study are summarized in Tables 3 and 4. The first indication of a possible carcinogenic response was observed in female mice. The incidence of hepatocellular tumors was elevated above background incidence at all dose groups and was statistically increased above background in the high-dose group (2). 36 3X. K. RAABE Table 3. Hepatocellular neoplasms in female mice reported and revised incidence summaries. Gasoline, Ppim Study 0 67 292 MacFairland (2) EPA incidence, summary (4) EPA incidence, cancerl potency (4) Revised by Richtei and MacGregor (personal communication, 1991) 8/57 (14);' 8/100 (8) 8/57 (14) 8/79 (10) 10/52 (19) 10/100 (10) 10/52 (19) 13/76 (17) 12/57 (21) 12/100 (12) 13/57 (23) 12/79 (15) 'Per-cent incidence in parentheses. 2056 '27/56 (48) 27/100 (27) 28/56 (50) 29/78 (37) Timor type Renal adlenoma Renal carcinoma Renal sarcoma Total Table 4. Renal tumor incidence in male rats from chronic exposure to unleaded gasoline vapors (2,3). Gasoline, ppim 0 (control) 67 292 2056 0/100 0/100 2/100 1/100 0/100 1/100 2/100 6/100 0/100 0/100 1/100 0/100 0/100 1/100 5/100 7/100 Days to first tumoi 546 692 748 The specific incidence rates have been reported differently by MacFarland and EPA as Table 3 illustrates. Recent reexamination of the slides and the original IRDC report by Richter and MacGregor (personal communication) suggest that previous rates were calculated incorrectly. In their revision, the total number of mice with hepatocellular tumors including neoplastic nodules, adenomas, and carcinomas are counted in the numerator. The denominator consists of all mice considered to be at risk; that is, all animals sacrificed or dying on study after 12 months, the time when the first hepatocellular tumor appeared. This revised incidence supports the main effect being predominantly in the high-dose group, which may provide some insight on mechanism. The major finding of the study related to the kidneys of male rats. At all interim sacrifices and in animals dying after 3 months, there was a dose-dependent increase in kidney lesions in male rats. These consisted of cortical renal tubular basophilia, protein casts, and chronic inflammation. This evidence for -cellular regeneration was distinguishable from progressive glomerulonephrosis or "old rat nephropathy," which by the time of final termination affected almost 100% of the male rats (2). Also observed at final termination was a dose-related incidence of microscopic renal cell neoplasms (Table 4). The cause of the nephropathy and its relationship to the renal neoplasms would become the focus of significant scientific inquiry. Mechanism It is unlikely that the carcinogenic response in the chronic study results from a direct mutagenic event. Unleaded gasoline has been studied extensively in mutagenic assays. Studies in Salmonella, yeast, mouse lymphoma in vivo cytogenetics, mouse dominant lethal systems, and rat cell DNA repair models all support the general conclusion that unleaded gasoline is not a mutagen (4). Coincident with the results of the gasoline chronic study, other petroleum compounds were becoming identi- fied as nephrotoxic in the male rat. By the time of the 1983 Workshop on the Renal Effects of Hydrocarbons, the general nature of this male rat nephrotoxicity was broadly acknowledged (5). This "light hydrocarbon nephropathy," as it was called, exhibited a pattern of degeneration, regeneration, dilation, and hyalin droplet formation in male rats but not in female rats or in male or female mice, cats, dogs, or monkeys. This nephropathy was found to be related to branched-chain aliphatic compounds (Table 5), with more highly branched compounds, particularly the eight carbon (C-8) compounds being more active (American Petroleum Institute, unpublished motor gasoline stud- ies, 1984, 1985). A rat specific protein, x2u-globulin, was determined to bind with these compounds and accumulate in renal tubule cells, resulting in cell death. The relevance of this mechanism of toxicity to the carcinogenic response in male rats and its more important possible relevance to man is reviewed by Swenberg and Rodgers in these proceedings (6,7). Human Evidence When examining the human evidence, one must first be reminded that the majority of human exposure to gasoline is from gasoline head space vapors being displaced in tanks during fueling operations. As Figure 1 illustrates, Table 5. Structure-activity relationships, light hydrocarbon nephropathy.1' Active Inactive 2-Methyl pentane 2,3-Dimethyl butane 2,2,5-Trimethyl hexane 2-Methyl hexane 2,3-Dimethyl pentane 2,2,4-Trimethyl pentane oi-Pentane 2-Methyl butane 2-Methyl pentene-2 Methyl clyclopentane ioi-Xylene o-Hexane t ra ns-Pentene-2 Toluene 1,2,4-Trimethyl benzene "Fr om American Petiroleum Institute (unpublished studies, 1984,1985). ('AIh( 'INO(;EAIC II'OTEA 7'IT4L OF GASOLINE % Composition 50 I i\ , Ii, Carbon # Vapor Liquid lo;i 1. .' Ypical g also0lineP vap1 o r- vei' s us g asolinle liquEidl cO ml})OSitiOnl. gasoline vapor is differenit in concentration and chemical species from that ofwholly vaporized unleaded gasoline; in particular, C-8 compounds are in lower concentr ations in the vapor than the liquid. This suggests that humans are less exposed to the agents most active in the male riat. A lar-ge number of epidemiologic studies of wlorkers in the petroleum industry have been conducted. Systematic rieviews of this literature by Wong and Raabe and an IARC monograph work group, both reported in 1989, represent the most comprehensive examination of these studies (8,9). Table 6 lists the major cohort studies reviewed by Wong and Raabe (8). The majority of these studies are of refinery wvorkers who, although exposed to gasolinelike hydr ocarbons, are generally not exposed to gasoline. The activities in the refining industry also potentially expose these wor ker s to other mater ials, some of which are known or suspect human carcinogens (e.g., asbestos, benzene, and polyaromatic hydrocarbons) (9). Unfortunately, none of the studies reviewed provide useful information about exposures. Nevertheless, an examination of liver cancei, kidney cancei, ancl leukemia in these populations provides some information on the possible risk from exposure to gasoline. Figure 2 summarizes the standardized mor-tality riatios (SMR) for liver cancer found in these studies. The metaSMR reported in this and subsequent figures was calculatedl by Wong and Raabe as an overall estimate of the industry experience (8). Looking at these stuclies individually or overall as summarized by the meta-SMR clear ly inclicates there is no evidence for an increased risk for liver cancer. Kidney cancer SMRs are summar ized in Figure 3. The patter n of SMRs for kidney cancer is less consistent than for liver cancer. Several studies show small excesses, in particular the study by Rushton of UK distribution workers. However, none of these excesses is statistically significant, and the overall meta-SMR is at the expected rate. Cohor t studies specific to gasoline-exposed worker s ar e needed before any f;irm conclusions can be drawn with egar d to human kidney cancer risk. Table 6. Petroleum cohort studies. Stud(y letter/author' Facility A. Nelson, 1985 10 Amoco iefiimei ies-l JS B. Woug et al., 1I986 Richmoncl, Fl SeguIn(lo- California, tUS Refinier ies C. Hauiis et al., 1985 Batoin Routge, LA, B aytown, TX, Bavwav NJ Refinei ies D. Wen et al., 1988) Port Arthul Iteftineix-Texas, ITS E. Mor-gani aind Wong, 1984 Beaumiiont Refinei--Texas, 11S F. Morgan an(d Wong, 1985 Paulsboiro Refiner -New Jerse>, tUS G. Enterline and(i Hen(lerson, 1985 Torrance Refiner(vdalifornia, US H. McGrav et al., 1985 Woodl River Refinerv -Illinois, US I. Jovner, 19883 Deer Park Refinev- Texas, US J. Divine et al., 1985 13 Texaco iefineiies-US K. Divine andl Barron, 1987 Productionamlllpieline - tS L. Rushton an(d Alderison, 1981 8 UK refineiies-tJnitedl King(lom M. Rushton andl Alderson, 19883 UK petroleum clist ibution centers - UTnite(d Kingclomii N. Theliault an(d Provencher, 1987 East Montreal Refinery-Canada 0. Chriistie et al., 1986 Austr alian petroleum industry- Australia P. Nakamunra, 1987 51 Japanese refineries - Japan META Wong and(I Raabe, 1989 Meta-analvsis of sttu(lies A-P 'Study! letter s correspond to the letters in Figuriles 2-4. All sttu(lies aire reviewedl in Wong and Raabe (8). Standardized Mortality Ratio 10 1 =~ 0.1 A B C D E F G L M P Meta Study Letter .Upper 95% Cl Lower 95% Cl + SMR 2v'.FI(;ul: Petr oleum cohor t studies: liver cancel' (Inter national Classi- fication of Disealse 15,5-156G). See Tahle 6; for studly letter dlefinitions. Adlaptedl fr om Wong an(l Raabe (8s). Standardized Mortality Ratio 10 m-- . . -. -- - ..---- -- -1--- ... .---- .. -- -- - . . . ...... liiI,iI , 0.11 A B C D E F G J K L M Meta Study Letter Upper 95% Cl Lower 95% Cl + SMR CFilc,arsuusiiiaficat8i.on Petroleumn of' Disease cohoi't 189). studlies: See Tahle kidney cancel (Inteinational 6 foi' study lettei' (lefinitions. Adapted fr-om Wong andl Raabe (8). 38 G. K. ILAABE Standardized Mortality Ratio ........................ ............. ...................... .,, , ........ _ '''''''' --''' :' ' 1.~~~~~~~~~~~~~~~~~~~~~~~~~~7 -. . J:::LM;O;ABi. ..,, ,. D F G HI K PMeta 0.1 A ABCDE FGH J K L M 0 P Meta Study Letter I Upper 95% Cl l Lower 95% Cl + SMR Fi(;t'IIE 4. Petiroleum cohort stu(dies: leukemia (Inter national Classification of Disease 204-207). See Table Ii for study letter (lefinitions. Adapted fr om Wong an(l Raabe (8). Leukemia risk from gasoline exposure associated with the small percentage of benzene in fuel continues to be of concern. Although it is generally recognized that exposures to benzene from automotive gasoline fueling are low (9), the misuse of gasoline as a solvent and large-scale distribution of gasoline in earlier time periods have not been well studied. Figure 4 shows the leukemia results from occupationally exposed petroleum cohort studies. Although not consistent across studies, there are indications that some refinery workers were historically at increased risk for leukemia. Again, the fact that the SMR in the UK-distribution worker study is elevated is of concern. As with human kidney cancer risk, studies specific to gasoline-exposed workers are needed before any conclusions can be drawn. Discussion Overall, the scientific history leading up to this symposium is a complex one. On one hand, we have clear evidence of a caicinogenic risk in animals. On the other hand, we have evolving mechanistic evidence indicating the male rat kidney cancer operates via a mechanism that is not relevant for man. Less is understood about the mouse liver cancer excess, but consistent epidemiologic evidence in petroleum-exposed workers argues against a gasolinerelated liver cancer r-isk for humans. To date, the studies in human populations have genelrally not provided adequate exposure information to help riesolve the uncertainty. Both IARC and EPA determined epidemiology studies as inadequate for making any judgment. It is against this background of scientific uncertainty that the new studies reported in these proceedings were intended to addiress. REFERENCES 1. Scala, R. A. Motor gasoline toxicity. Fundaimi. Appl. Toxicol. 10: 553562 (1988). 2. MacFarland, H. N., Ulrich, C. E., Holdsworth, C. E., Kitchen, D. N., HalliWell, W. H., an(d Bum, S. C. A Chronic inhalation study of unleaded gasoline vapor: J. Am. Coll. Toxicol. 3: 231-248 (1984). 3. IRDC. Motor Fuel Chronic Inhalation Study, Vols. 1-6 (sponsored by the American Petroleum Institute). International Research and Development Corporation, Mattawan, MI, 1983. 4. U.S. EPA. Evaluation of the Carcinogenicity of Unlea(led Gasolinie. EPA/600/6-87/001, U.S. Environimiental Protection Agency, 1987. 5. Alden, C. L., Kanerva, B. A., Riddei- G., and Stone, L. C. The pathogenesis of the nephrotoxicity of volatile hydrocalbons in the male riat. In: Renal Effects of Petroleum Hyvdrocar bons, Vol. 7 (M. A. Mehlman, Ed.), Princeton Scientific Publishers, Princeton, NJ, 1984, pp. 107-120. 6. Swenberg, J. Carcinogenic mechanisms of unlea(led gasoline. Environ. Health Perspect. 101(Suppl. 6): 39-44 (1993). 7. Sevin Rodgers, I. Interpretation of male riat renal tubule tumors. Environ. Health Perspect. 101(Suppl. 6): 45-52 (1993). 8. Wong, O., and Raabe, G. K. Critical review of cancer epidemiology in petroleum industry employees, wAith a quantitative meta-analysis by cancer site. Am. J. Ind. Med. 15: 283-310 (1989). 9. IARC. Monographs on the Evaluation of Carcinogen Risks to Man, Vol. 45. Occupational Exposures in the Petroleum Refining; Cru(le Oil andl Major Petroleum Fuels. International Agency for Research on Cancer, Lyon, 1989.